1. Home
  2. ABVC vs SURG Comparison

ABVC vs SURG Comparison

Compare ABVC & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABVC
  • SURG
  • Stock Information
  • Founded
  • ABVC 2015
  • SURG 2006
  • Country
  • ABVC United States
  • SURG United States
  • Employees
  • ABVC N/A
  • SURG N/A
  • Industry
  • ABVC Biotechnology: Pharmaceutical Preparations
  • SURG Advertising
  • Sector
  • ABVC Health Care
  • SURG Consumer Discretionary
  • Exchange
  • ABVC Nasdaq
  • SURG Nasdaq
  • Market Cap
  • ABVC 52.1M
  • SURG 58.6M
  • IPO Year
  • ABVC N/A
  • SURG N/A
  • Fundamental
  • Price
  • ABVC $3.24
  • SURG $2.85
  • Analyst Decision
  • ABVC
  • SURG Strong Buy
  • Analyst Count
  • ABVC 0
  • SURG 1
  • Target Price
  • ABVC N/A
  • SURG $9.50
  • AVG Volume (30 Days)
  • ABVC 103.1K
  • SURG 90.8K
  • Earning Date
  • ABVC 11-13-2025
  • SURG 11-11-2025
  • Dividend Yield
  • ABVC N/A
  • SURG N/A
  • EPS Growth
  • ABVC N/A
  • SURG N/A
  • EPS
  • ABVC N/A
  • SURG N/A
  • Revenue
  • ABVC $391,242.00
  • SURG $36,461,935.00
  • Revenue This Year
  • ABVC $735.18
  • SURG $47.01
  • Revenue Next Year
  • ABVC N/A
  • SURG $81.15
  • P/E Ratio
  • ABVC N/A
  • SURG N/A
  • Revenue Growth
  • ABVC 186.84
  • SURG N/A
  • 52 Week Low
  • ABVC $0.40
  • SURG $1.05
  • 52 Week High
  • ABVC $5.48
  • SURG $3.47
  • Technical
  • Relative Strength Index (RSI)
  • ABVC 61.30
  • SURG 45.96
  • Support Level
  • ABVC $2.99
  • SURG $2.51
  • Resistance Level
  • ABVC $3.39
  • SURG $2.90
  • Average True Range (ATR)
  • ABVC 0.17
  • SURG 0.14
  • MACD
  • ABVC 0.02
  • SURG -0.02
  • Stochastic Oscillator
  • ABVC 74.23
  • SURG 35.76

About ABVC ABVC BioPharma Inc.

ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

Share on Social Networks: